Brian focuses his practice on representing a broad array of clients in merger and non-merger antitrust investigations. He is a former Department of Justice (DOJ) Antitrust Division attorney who represents clients before the DOJ and the Federal Trade Commission (FTC). A go-to lawyer for clients facing antitrust agency scrutiny, Brian has substantial experience guiding clients through challenging merger investigations.

Brian leads Akin’s Hart-Scott-Rodino (HSR) premerger filing practice, including advising on HSR reportability issues and preparing and submitting HSR filings. He also routinely advises on antitrust compliance issues, such as interlocking directorates, information exchanges, distribution and franchising, monopolistic conduct and joint ventures (JVs).

With clients across industries, Brian advises companies and investors in energy (including oil & gas), health care & life sciences, manufacturing, consumer products, chemicals, airlines, technology, semiconductors and various other industries.

In addition, Brian defends companies in litigated merger challenges brought by the government. He represented chemical producer PeroxyChem in its trial victory against the FTC in its attempt to block the $640 million sale of PeroxyChem to Evonik. Brian also represented General Electric in Electrolux/General Electric, Monsanto in Deere/Monsanto and Phoebe Putney hospital in Phoebe Putney/Palmyra Park.

Prior to joining Akin, Brian was an antitrust associate at two other prominent D.C. law firms and served as a trial attorney at the DOJ Antitrust Division’s Defense, Industrials and Aerospace Section (DIA).